The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Editorial
PreviousPrevious
Volume 344:1392-1393 May 3, 2001 Number 18
NextNext

Racial Profiling in Medical Research

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
 by Exner, D. V.
-Related Article
 by Yancy, C. W.
-PubMed Citation
Two articles in this issue of the Journal deal with the treatment of heart failure in white and black patients. One, concerning carvedilol, reports that the benefit of this beta-blocker is similar in nonblacks and blacks with chronic heart failure.1 The other contends that enalapril, an angiotensin-converting–enzyme inhibitor, is more effective in whites than in blacks with left ventricular dysfunction.2 The authors of both articles refer to "race," "racial groups," "racial differences," and "ethnic background" but offer no plausible biologic justification for making such distinctions. In a nod to the quandary faced by anyone who tries to explain the complex . . . [Full Text of this Article]

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.